Clinical Laboratory Billing Services

Catch them at accession rather than after denial. A test ordered with a vague or screening code will not support medical necessity, and you cannot supply a diagnosis yourself because it must come from the ordering provider. Validating the diagnosis before the specimen is resulted lets you query the practice while the order is still current and correctable.

No. The diagnosis must come from the ordering provider and reflect their clinical assessment. Altering it to secure payment is a serious compliance problem regardless of how obvious the correct code seems. The right approach is querying the practice for clarification and documenting their response, which protects the laboratory and produces a legitimately payable claim.

Usually because component tests were billed individually when the combination must be reported as a panel. Payers apply automatic edits that collapse those components and reduce the payment, sometimes flagging the pattern for review. Building panel logic into claim creation prevents it entirely, which matters because at laboratory volumes this error repeats constantly.

Check the patient's prior testing history against the applicable interval before billing. Many monitoring tests are covered only at set intervals, and repeats inside that window need a documented clinical reason from the ordering provider. Because laboratories rarely see the full clinical picture, flagging these at accession lets the practice supply the justification early.

Flag them at accession so advance notice can be given before the test is performed. Once a non-covered test is resulted without notice, the balance is usually not collectable from the patient. Identifying these upfront lets the referring practice either supply better justification or inform the patient, which protects everyone involved.

Under a client billing arrangement, the referring practice pays the laboratory directly and bills the patient or insurer themselves. It is a contractual relationship set per account, not a per-specimen decision. Confusion between client-billed and insurance-billed accounts causes both duplicate billing and missed revenue. We configure the route on the account so it applies automatically.

Because insurance details arrive from the referring office and errors enter your claims upstream. You inherit their registration mistakes at your volume rather than theirs. Validating inbound demographics at accession catches most of it, and reporting error rates back by referring client usually prompts a fix at the source rather than endless rework.

With considerably more front-end work than routine chemistry. These tests are high value, frequently require prior authorisation, and carry specific coverage criteria referencing particular clinical circumstances. Performing one without confirming coverage first risks a large unrecoverable loss. We screen these separately from routine testing so they never run on an assumption.

Yes. The laboratory itself must be enrolled and contracted with each payer, and it must hold the appropriate certification for the complexity of testing performed. Billing tests outside your certification level produces denials and compliance exposure. We confirm certification scope against your test menu, which practices adding new assays often overlook.

Denial and error rates broken out by referring client. Laboratory denials almost always concentrate with a handful of ordering practices rather than spreading evenly, and that turns an abstract quality problem into a specific conversation with a specific office. Fixing the source is far more effective than reworking claims indefinitely at volume.